Google+

ROCA and ovarian cancer screening

Congratulations to Abcodia, the biomarker validation company I work with, which has been granted world-wide exclusive license for ROCA, a test which has the potential to be a major breakthrough for the early diagnosis of ovarian cancer. ROCA, which stands for the Risk of Ovarian Cancer Algorithm, is being validated for the screening of ovarian cancer. It has been used in studies involving more...
read more


Google+